Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-005826
Filing Date
2022-02-16
Accepted
2022-02-16 21:03:01
Documents
2
Period of Report
2022-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6260
2 EXHIBIT 24 brhc10034160_ex24.htm EX-24 8721
  Complete submission text file 0001140361-22-005826.txt   16445
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Patel Kinnari (Reporting) CIK: 0001725929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 22645421